SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $280,018 | +5.9% | 2,310 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $264,541 | -16.9% | 2,310 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $318,387 | +8.7% | 2,310 | +2.2% | 0.00% | 0.0% |
Q4 2022 | $292,980 | -97.9% | 2,261 | -98.2% | 0.00% | -98.4% |
Q3 2022 | $14,036,000 | +6110.6% | 126,975 | +4112.8% | 0.06% | +6100.0% |
Q2 2022 | $226,000 | -98.5% | 3,014 | -98.5% | 0.00% | -98.1% |
Q1 2022 | $15,387,000 | -13.2% | 196,969 | 0.0% | 0.05% | -16.9% |
Q4 2021 | $17,737,000 | -37.1% | 196,969 | -35.4% | 0.06% | -43.0% |
Q3 2021 | $28,219,000 | +32.3% | 305,131 | +11.2% | 0.11% | +32.6% |
Q2 2021 | $21,330,000 | +9729.5% | 274,380 | +9315.9% | 0.09% | +8500.0% |
Q1 2021 | $217,000 | -54.5% | 2,914 | +4.2% | 0.00% | -50.0% |
Q4 2020 | $477,000 | +21.4% | 2,796 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $393,000 | -10.1% | 2,796 | +2.5% | 0.00% | -33.3% |
Q2 2020 | $437,000 | +63.7% | 2,727 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $267,000 | -24.1% | 2,727 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $352,000 | 0.0% | 2,727 | +17.7% | 0.00% | 0.0% |
Q2 2019 | $352,000 | +27.5% | 2,317 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $276,000 | +9.1% | 2,317 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $253,000 | -32.4% | 2,317 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $374,000 | +22.2% | 2,317 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $306,000 | – | 2,317 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |